Literature DB >> 15261488

Nitric oxide and cerebral ischemic preconditioning.

Paul L Huang1.   

Abstract

Nitric oxide (NO) is an important mediator of cerebral blood flow and metabolism. As a vasodilator, NO regulates cerebral blood flow, and couples regional brain perfusion with metabolic activity. Following cerebral ischemia, NO levels rise significantly due to activation of neuronal nitric oxide synthase by NMDA receptor mediated calcium entry. Depending on its tissue and enzymatic source, NO may be protective or toxic. This article reviews the effects of NO following cerebral ischemia, the signaling pathways through which NO acts, and its potential roles in cerebral ischemic preconditioning.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15261488     DOI: 10.1016/j.ceca.2004.02.007

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  25 in total

1.  GTP cyclohydrolase 1 gene 3'-UTR C+243T variant predicts worsening outcome in patients with first-onset ischemic stroke.

Authors:  Ling Tang; Lan Zhang; Hu Ding; Wei Tu; Jiangtao Yan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

Review 2.  Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain.

Authors:  Hideto Kitano; Jeffrey R Kirsch; Patricia D Hurn; Stephanie J Murphy
Journal:  J Cereb Blood Flow Metab       Date:  2006-10-18       Impact factor: 6.200

3.  Inositol 1,4,5-triphosphate receptors and NAD(P)H mediate Ca2+ signaling required for hypoxic preconditioning of hippocampal neurons.

Authors:  P E Bickler; C S Fahlman; J Gray; W McKleroy
Journal:  Neuroscience       Date:  2009-02-13       Impact factor: 3.590

Review 4.  Ischemic tolerance as an active and intrinsic neuroprotective mechanism.

Authors:  R Anne Stetler; Feng Zhang; Collin Liu; Jun Chen
Journal:  Handb Clin Neurol       Date:  2009

5.  Endoplasmic reticulum refilling and mitochondrial calcium extrusion promoted in neurons by NCX1 and NCX3 in ischemic preconditioning are determinant for neuroprotection.

Authors:  M J Sisalli; A Secondo; A Esposito; V Valsecchi; C Savoia; G F Di Renzo; L Annunziato; A Scorziello
Journal:  Cell Death Differ       Date:  2014-03-14       Impact factor: 15.828

Review 6.  Beyond anoxia: the physiology of metabolic downregulation and recovery in the anoxia-tolerant turtle.

Authors:  Sarah L Milton; Howard M Prentice
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2006-09-05       Impact factor: 2.320

Review 7.  Isoflurane provides neuroprotection in neonatal hypoxic ischemic brain injury.

Authors:  Sherrefa R Burchell; Brandon J Dixon; Jiping Tang; John H Zhang
Journal:  J Investig Med       Date:  2013-10       Impact factor: 2.895

8.  Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection.

Authors:  Aysan Durukan; Turgut Tatlisumak
Journal:  Exp Transl Stroke Med       Date:  2010-01-21

Review 9.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

Review 10.  Inhalational anesthetics as preconditioning agents in ischemic brain.

Authors:  Lan Wang; Richard J Traystman; Stephanie J Murphy
Journal:  Curr Opin Pharmacol       Date:  2007-10-24       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.